Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: Pathogenic interactions and therapeutic considerations

Free Radical Biology and Medicine

Volumn 52, Issue 7, 2012, Pages 1135-1150

  Choi, Jinah ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiviral therapy; EpRE; Ethanol; Free radicals; Glutathione; HCV; Hepatocellular carcinoma; Hydrogen peroxide; Interferon; Mitochondria; Mutation; NAD(P)H oxidase; Pathogenesis; Positive selection; Replication; Toll like receptor

Indexed keywords

ALCOHOL; ANTIOXIDANT; CYTOCHROME P450 2E1; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANTIVIRAL RESISTANCE; FATTY LIVER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MEMBRANE PERMEABILITY; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL MEMBRANE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENSITIZATION; VIRUS GENOME; VIRUS REPLICATION;

ALCOHOLS; ANTIOXIDANTS; ANTIVIRAL AGENTS; HEPACIVIRUS; HEPATITIS C; HUMANS; OXIDATIVE STRESS;

ANIMALIA; HEPATITIS C VIRUS; NON-A, NON-B HEPATITIS VIRUS;

EID: 84862820415     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.01.008     Document Type: Review

References (356)

1. M.J. Tong Clinical outcomes after transfusion-associated hepatitis C N. Engl. J. Med. 332 1995 1463 1466
2. Hepatocellular carcinoma-United States, 2001-2006 CDC Morbidity and Mortality Weekly Report 2010 Centers for Disease Control and Prevention Atlanta 517 520
3. G.L. Davis Projecting future complications of chronic hepatitis C in the United States Liver Transpl. 9 2003 331 338 (Pubitemid 36443043)
4. M. Wise Changing trends in hepatitis C-related mortality in the United States, 1995-2004 Hepatology 47 2008 1128 1135 (Pubitemid 351547899)
5. M.W. Fried Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N. Engl. J. Med. 347 2002 975 982
6. W.P. Hofmann, S. Zeuzem, and C. Sarrazin Hepatitis C virus-related resistance mechanisms to interferon α-based antiviral therapy J. Clin. Virol. 32 2005 86 91 (Pubitemid 40093958)
7. M.P. Manns Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 2001 958 965 (Pubitemid 32913521)
8. J. Vermehren, and C. Sarrazin New HCV therapies on the horizon Clin. Microbiol. Infect. 17 2011 122 134
9. P. Simmonds Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes Hepatology 42 2005 962 973 (Pubitemid 41401136)
10. N.N. Zein Clinical significance of hepatitis C virus genotypes Clin. Microbiol. Rev. 13 2000 223 235 (Pubitemid 30205426)
11. K. Chayama, and C.N. Hayes Hepatitis C virus: how genetic variability affects pathobiology of disease J. Gastroenterol. Hepatol. 26 Suppl. 1 2011 83 95
12. M. Irshad HCV-genotypes: a review on their origin, global status, assay system, pathogenecity and response to treatment Hepatogastroenterology 57 2010 1529 1538
13. M. Ripoli, and V. Pazienza Impact of HCV genetic differences on pathobiology of disease Expert Rev. Anti Infect. Ther. 9 2011 747 759
14. D. Moradpour, F. Penin, and C.M. Rice Replication of hepatitis C virus Nat. Rev. Microbiol. 5 2007 453 463 (Pubitemid 46780082)
15. Z. Xu Synthesis of a novel hepatitis C virus protein by ribosomal frameshift EMBO J. 20 2001 3840 3848 (Pubitemid 32691795)
16. J. Choi, Z. Xu, and J.H. Ou Triple decoding of hepatitis C virus RNA by programmed translational frameshifting Mol. Cell. Biol. 23 2003 1489 1497 (Pubitemid 36246032)
17. J.L. Walewski Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame RNA 7 2001 710 721 (Pubitemid 32405868)
18. A. Varaklioti Alternate translation occurs within the core coding region of the hepatitis C viral genome J. Biol. Chem. 277 2002 17713 17721 (Pubitemid 34967576)
19. D. Moradpour Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes J. Virol. 78 2004 7400 7409 (Pubitemid 38915885)
20. S.T. Shi Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2 J. Virol. 77 2003 4160 4168 (Pubitemid 36350955)
21. R. Gosert Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons J. Virol. 77 2003 5487 5492 (Pubitemid 36460961)
22. J. Choi Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells Hepatology 39 2004 81 89 (Pubitemid 38461470)
23. V. Lohmann Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line Science 285 1999 110 113 (Pubitemid 29307577)
24. K.J. Blight, A.A. Kolykhalov, and C.M. Rice Efficient initiation of HCV RNA replication in cell culture Science 290 2000 1972 1974
25. T. Wakita Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat. Med. 11 2005 791 796 (Pubitemid 41021213)
26. J. Zhong Robust hepatitis C virus infection in vitro Proc. Natl. Acad. Sci. U. S. A. 102 2005 9294 9299 (Pubitemid 40923557)
27. B.D. Lindenbach Complete replication of hepatitis C virus in cell culture Science 309 2005 623 626 (Pubitemid 41033648)
28. K. Banaudha Primary hepatocyte culture supports hepatitis C virus replication: a model for infection-associated hepatocarcinogenesis Hepatology 51 2010 1922 1932
29. P. Podevin Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes Gastroenterology 139 2010 1355 1364
30. C.T. Jones Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system Nat. Biotechnol. 28 2010 167 171
31. T. Heller An in vitro model of hepatitis C virion production Proc. Natl. Acad. Sci. U. S. A. 102 2005 2579 2583 (Pubitemid 40279419)
32. T. Kato Production of infectious hepatitis C virus of various genotypes in cell cultures J. Virol. 81 2007 4405 4411 (Pubitemid 46668637)
33. M. Triyatni, E.A. Berger, and B. Saunier A new model to produce infectious hepatitis C virus without the replication requirement PLoS Pathog. 7 2011 e1001333
34. S. Seronello, M.Y. Sheikh, and J. Choi Redox regulation of hepatitis C in nonalcoholic and alcoholic liver Free Radic. Biol. Med. 43 2007 869 882 (Pubitemid 47223633)
35. G. Barbaro Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype J. Hepatol. 30 1999 774 782 (Pubitemid 29248975)
36. W.S. Ko Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C World J. Gastroenterol. 11 2005 4697 4702
37. W.A. Peres Vitamin A deficiency in patients with hepatitis C virus-related chronic liver disease Br. J. Nutr. 106 2011 1724 1731
38. H. Takagi Pilot clinical trial of the use of α-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis Int. J. Vitam. Nutr. Res. 73 2003 411 415 (Pubitemid 38009807)
39. C.C. Lin, and M.C. Yin Vitamin B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon α and ribavirin Clin. Nutr. 28 2009 34 38
40. J. Madill Oxidative stress and nutritional factors in hepatitis C virus-positive liver recipients, controls, and hepatitis C virus-positive nontransplant patients Transplant. Proc. 42 2010 1744 1749
41. F. Farinati Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection Free Radic. Biol. Med. 27 1999 1284 12891
42. K. Moriya Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis Cancer Res. 61 2001 4365 4370 (Pubitemid 32685760)
43. M. Okuda Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein Gastroenterology 122 2002 366 375 (Pubitemid 34116988)
44. S. Mahmood Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C Antioxid. Redox Signal. 6 2004 19 24 (Pubitemid 38063973)
45. S.K. Jain Oxidative stress in chronic hepatitis C: not just a feature of late stage disease J. Hepatol. 36 2002 805 811 (Pubitemid 35177411)
46. C. Garcia-Monzon Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease J. Hepatol. 32 2000 331 338 (Pubitemid 30093914)
47. R. Cardin DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study J. Hepatol. 34 2001 587 592 (Pubitemid 32328517)
48. U. Mutlu-Turkoglu The effects of interferon-α on serum lipid peroxidation and total thiol content in patients with chronic active hepatitis-C Res. Commun. Mol. Pathol. Pharmacol. 96 1997 357 361 (Pubitemid 27329989)
49. V. Higueras Interferon decreases serum lipid peroxidation products of hepatitis C patients Free Radic. Biol. Med. 16 1994 131 133
50. F. Kageyama Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C Am. J. Gastroenterol. 95 2000 1041 1050 (Pubitemid 30196744)
51. C. Hezode Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions J. Hepatol. 31 1999 979 984
52. F. Farinati Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis J. Hepatol. 22 1995 449 456
53. D. Thorburn The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C Gut 50 2002 248 252 (Pubitemid 34087940)
54. N. Fujita Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients Free Radic. Biol. Med. 42 2007 353 362 (Pubitemid 46038043)
55. J. Emerit, C. Beaumont, and F. Trivin Iron metabolism, free radicals, and oxidative injury Biomed. Pharmacother. 55 2001 333 339 (Pubitemid 32595478)
56. J. Kato Normalization of elevated hepatic 8-hydroxy-2′- deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet Cancer Res. 61 2001 8697 8702 (Pubitemid 34013879)
57. K. Machida Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes J. Virol. 78 2004 8835 8843
58. K. Machida Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes Proc. Natl. Acad. Sci. U. S. A. 101 2004 4262 4267
59. K. Machida Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation J. Virol. 80 2006 7199 7207
60. S. Burney The chemistry of DNA damage from nitric oxide and peroxynitrite Mutat. Res. 424 1999 37 49 (Pubitemid 29101606)
61. C.C. Winterbourn Toxicity of iron and hydrogen peroxide: the Fenton reaction Toxicol. Lett. 82-83 1995 969 974 (Pubitemid 26054777)
62. K. Miura Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity Hepatology 48 2008 1420 1429
63. S. Jahan Role of HCV core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis Virol. J. 8 2011 155
64. D.R. McGivern, and S.M. Lemon Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer Oncogene 30 2011 1969 1983
65. G. Castello, S. Costantini, and S. Scala Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment J. Transl. Med. 8 2010 109
66. F. Capone Serum cytokine levels in patients with hepatocellular carcinoma Eur. Cytokine Netw. 21 2010 99 104
67. J.M. Roberts, J.W. Searle, and W.G. Cooksley Histological patterns of prolonged hepatitis C infection Gastroenterol. Jpn. 28 Suppl. 5 1993 37 41 (Pubitemid 23215457)
68. J.A. Mengshol A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection PLoS One 5 2010 e9504
69. N. Hosomura HCV-related proteins activate Kupffer cells isolated from human liver tissues Dig. Dis. Sci. 56 2011 1057 1064
70. F. Thoren A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals J. Leukoc. Biol. 76 2004 1180 1186 (Pubitemid 39602954)
71. C. Bureau Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase J. Biol. Chem. 276 2001 23077 23083
72. A. Dolganiuc Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection Gastroenterology 133 2007 1627 1636 (Pubitemid 350029734)
73. J.D. Lambeth NOX enzymes and the biology of reactive oxygen Nat. Rev. Immunol. 4 2004 181 189 (Pubitemid 38339084)
74. Q. Lin HCV peptide (C5A), an amphipathic α-helical peptide of hepatitis virus C, is an activator of N-formyl peptide receptor in human phagocytes J. Immunol. 186 2011 2087 2094
75. G. Barbaro Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings Am. J. Gastroenterol. 94 1999 2198 2205 (Pubitemid 29374554)
76. G. Gong Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB Proc. Natl. Acad. Sci. U. S. A. 98 2001 9599 9604 (Pubitemid 32769349)
77. M. Korenaga Hepatitis C virus core protein inhibits mitochondrial electron transport and increases ROS production J. Biol. Chem. 280 2005 37481 37488 (Pubitemid 41642356)
78. 2 + uniporter activity FASEB J. 21 2007 2474 2485 (Pubitemid 47230677)
79. J. Choi, and J.H. Ou Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus Am. J. Physiol. Gastrointest. Liver Physiol. 290 2006 G847 G851
80. C. Piccoli Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress Hepatology 46 2007 58 65 (Pubitemid 47171921)
81. G. Szabo Alcohol and hepatitis C virus-interactions in immune dysfunctions and liver damage Alcohol. Clin. Exp. Res. 34 2010 1675 1686
82. T. Wang Role of hepatitis C virus core protein in viral-induced mitochondrial dysfunction J. Viral Hepat. 17 2010 784 793
83. N.L. Benali-Furet Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion Oncogene 24 2005 4921 4933 (Pubitemid 41129096)
84. K.D. Tardif, G. Waris, and A. Siddiqui Hepatitis C virus, ER stress, and oxidative stress Trends Microbiol. 13 2005 159 163 (Pubitemid 40463317)
85. N.S. de Mochel Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection Hepatology 52 2010 47 59
86. H.E. Boudreau Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor β-dependent manner: a new contributor to HCV-induced oxidative stress J. Virol. 83 2009 12934 12946
87. L. Caja Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-β-induced cell death through impairing up-regulation of the NADPH oxidase NOX4 Cancer Res. 69 2009 7595 7602
88. I. Carmona-Cuenca Upregulation of the NADPH oxidase NOX4 by TGF-β in hepatocytes is required for its pro-apoptotic activity J. Hepatol. 49 2008 965 976
89. M.M. Murillo Activation of NADPH oxidase by transforming growth factor-β in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-κB-dependent mechanism Biochem. J. 405 2007 251 259 (Pubitemid 47075160)
90. P. Sancho The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-β-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms Biochim. Biophys. Acta 1793 2009 253 263
91. R. Reinehr Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis J. Biol. Chem. 280 2005 27179 27194 (Pubitemid 41040757)
92. R. Reinehr Bile salt-induced apoptosis involves NADPH oxidase isoform activation Gastroenterology 129 2005 2009 2031 (Pubitemid 41772977)
93. T. Naas Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2 J. Gen. Virol. 86 Pt 8 2005 2185 2196 (Pubitemid 41057523)
94. R.M. Liu Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor β1-induced expression of plasminogen activator inhibitor 1 in fibroblasts J. Biol. Chem. 285 2010 16239 16247
95. I. Cucoranu NAD(P)H oxidase 4 mediates transforming growth factor-β1-induced differentiation of cardiac fibroblasts into myofibroblasts Circ. Res. 97 2005 900 907 (Pubitemid 41552675)
96. L. Hecker NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury Nat. Med. 15 2009 1077 1081
97. T. Hu Reactive oxygen species production via NADPH oxidase mediates TGF-β-induced cytoskeletal alterations in endothelial cells Am. J. Physiol. Renal Physiol. 289 2005 F816 F825
98. A. Sturrock Nox4 mediates TGF-β1-induced retinoblastoma protein phosphorylation, proliferation, and hypertrophy in human airway smooth muscle cells Am. J. Physiol. Lung Cell. Mol. Physiol. 292 2007 L1543 L1555
99. H. Taniguchi Hepatitis C virus core protein upregulates transforming growth factor-β1 transcription J. Med. Virol. 72 2004 52 59 (Pubitemid 37484743)
100. W. Lin Hepatitis C virus regulates transforming growth factor β1 production through the generation of reactive oxygen species in a nuclear factor κB-dependent manner Gastroenterology 138 2010 2509 2518 2518 e1
101. A. Manea Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 30 2010 105 112
102. G. Perlemuter Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model J. Hepatol. 39 2003 1020 1027 (Pubitemid 37523775)
103. P.A. Gochee Steatosis in chronic hepatitis C: association with increased messenger RNA expression of collagen I, tumor necrosis factor-α and cytochrome P450 2E1 J. Gastroenterol. Hepatol. 18 2003 386 392 (Pubitemid 36549548)
104. K.T. Moe Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-α in human aortic smooth muscle and embryonic kidney cells J. Cell. Mol. Med. 10 2006 231 239 (Pubitemid 44874305)
105. Y. Kuwano Interferon-γ activates transcription of NADPH oxidase 1 gene and upregulates production of superoxide anion by human large intestinal epithelial cells Am. J. Physiol. Cell Physiol. 290 2006 C433 C443
106. Y.S. Kim TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death Mol. Cell 26 2007 675 687
107. R. Gonzalez-Amaro Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis J. Exp. Med. 179 1994 841 848 (Pubitemid 24065641)
108. E. Ogier-Denis, S.B. Mkaddem, and A. Vandewalle NOX enzymes and Toll-like receptor signaling Semin. Immunopathol. 30 2008 291 300
109. H.S. Park Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-κB J. Immunol. 173 2004 3589 3593 (Pubitemid 39280716)
110. E. Chiang Cutting edge: apoptosis-regulating signal kinase 1 is required for reactive oxygen species-mediated activation of IFN regulatory factor 3 by lipopolysaccharide J. Immunol. 176 2006 5720 5724
111. A.G. Testro, and K. Visvanathan Toll-like receptors and their role in gastrointestinal disease J. Gastroenterol. Hepatol. 24 2009 943 954
112. G.R. Anderson Regulation of the CYP1A1 gene by 2,3,7,8- tetrachlorodibenzo-p-dioxin but not by β-naphthoflavone or 3-methylcholanthrene is altered in hepatitis C virus replicon-expressing cells Mol. Pharmacol. 70 2006 1062 1070 (Pubitemid 44268463)
113. A.I. Cederbaum CYP2E1-dependent toxicity and oxidative stress in HepG2 cells Free Radic. Biol. Med. 31 2001 1539 1543 (Pubitemid 34024976)
114. C.S. Lieber Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases Adv. Pharmacol. 38 1997 601 628
115. M. Morimoto Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis Alcohol 10 1993 459 464 (Pubitemid 24012668)
116. B.H. Lauterburg, S. Davies, and J.R. Mitchell Ethanol suppresses hepatic glutathione synthesis in rats in vivo J. Pharmacol. Exp. Ther. 230 1984 7 11 (Pubitemid 14097651)
117. C. Rigamonti Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C Hepatology 38 2003 42 49 (Pubitemid 36775794)
118. K. Otani Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells Gastroenterology 128 2005 96 107 (Pubitemid 40039962)
119. G. Novitskiy Effects of ethanol and acetaldehyde on reactive oxygen species production in rat hepatic stellate cells Alcohol. Clin. Exp. Res. 30 2006 1429 1435 (Pubitemid 44114695)
120. + J. Biol. Chem. 285 2010 845 854
121. G. Barbaro Hepatic glutathione deficiency in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease Am. J. Gastroenterol. 91 1996 2569 2573
122. K. Swietek, and J. Juszczyk Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis J. Viral Hepat. 4 1997 139 141 (Pubitemid 127736549)
123. M.Y. Abdalla Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses J. Med. Virol. 76 2005 489 497 (Pubitemid 40943258)
124. H.J. Forman, H. Zhang, and A. Rinna Glutathione: overview of its protective roles, measurement, and biosynthesis Mol. Aspects Med. 30 2009 1 12
125. D.A. Dickinson Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression FASEB J. 17 2003 473 475
126. H. Zhang, and H.J. Forman Signaling pathways involved in phase II gene induction by α, β-unsaturated aldehydes Toxicol. Ind. Health 25 2009 269 278
127. M. Carvajal-Yepes Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins J. Biol. Chem. 286 2011 8941 8951
128. K. Moriya Hepatitis C virus core protein compromises iron-induced activation of antioxidants in mice and HepG2 cells J. Med. Virol. 82 2010 776 792
129. M.Y. Abdalla Down-regulation of heme oxygenase-1 by hepatitis C virus infection in vivo and by the in vitro expression of hepatitis C core protein J. Infect. Dis. 190 2004 1109 1118 (Pubitemid 39186798)
130. F. Wen Hepatitis C core protein inhibits induction of heme oxygenase-1 and sensitizes hepatocytes to cytotoxicity Cell Biol. Toxicol. 24 2008 175 188 (Pubitemid 351311393)
131. M. Morbitzer, and T. Herget Expression of gastrointestinal glutathione peroxidase is inversely correlated to the presence of hepatitis C virus subgenomic RNA in human liver cells J. Biol. Chem. 280 2005 8831 8841 (Pubitemid 40409572)
132. Y. Sumida Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection J. Hepatol. 33 2000 616 622
133. E. Larrea Superoxide dismutase in patients with chronic hepatitis C virus infection Free Radic. Biol. Med. 24 1998 1235 1241 (Pubitemid 28246738)
134. T. Ghaziani HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells J. Hepatol. 45 2006 5 12 (Pubitemid 43850616)
135. Y. Hara Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species J. Gastroenterol. 41 2006 257 268
136. I. Qadri Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1 Biochem. J. 378 Pt 3 2004 919 928 (Pubitemid 38406869)
137. W.H. Hou Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells World J. Gastroenterol. 15 2009 4499 4510
138. D. Burdette, M. Olivarez, and G. Waris Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway J. Gen. Virol. 91 Pt 3 2010 681 690
139. P. Brennan, and L.A. O'Neill 2-Mercaptoethanol restores the ability of nuclear factor κB (NF κB) to bind DNA in nuclear extracts from interleukin 1-treated cells incubated with pyrollidine dithiocarbamate (PDTC): evidence for oxidation of glutathione in the mechanism of inhibition of NF κB by PDTC Biochem. J. 320 Pt 3 1996 975 981
140. G.W. Verhaegh, M.J. Richard, and P. Hainaut Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper Mol. Cell. Biol. 17 1997 5699 5706 (Pubitemid 27411077)
141. A.C. Wild, and R.T. Mulcahy Pyrrolidine dithiocarbamate up-regulates the expression of the genes encoding the catalytic and regulatory subunits of γ-glutamylcysteine synthetase and increases intracellular glutathione levels Biochem. J. 338 Pt 3 1999 659 665 (Pubitemid 29140070)
142. O. Beloqui N-acetyl cysteine enhances the response to interferon-α in chronic hepatitis C: a pilot study J. Interferon Res. 13 1993 279 282 (Pubitemid 23318490)
143. R. Faraonio p53 suppresses the Nrf2-dependent transcription of antioxidant response genes J. Biol. Chem. 281 2006 39776 39784 (Pubitemid 46041781)
144. R. Liu, and J. Choi Age-associated decline in γ-glutamylcysteine synthetase gene expression in rats Free Radic. Biol. Med. 28 2000 566 574 (Pubitemid 30136038)
145. S. Levy, and H.J. Forman C-Myc is a Nrf2-interacting protein that negatively regulates phase II genes through their electrophile responsive elements IUBMB Life 62 2010 237 246
146. W. Lu Activation of p53 tumor suppressor by hepatitis C virus core protein Virology 264 1999 134 141 (Pubitemid 29531894)
147. M. Otsuka Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability J. Biol. Chem. 275 2000 34122 34130
148. M. Honda Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells Hepatology 31 2000 1351 1359 (Pubitemid 30351299)
149. W.B. Wu Hepatitis C virus F protein up-regulates c-myc and down-regulates p53 in human hepatoma HepG(2) cells Intervirology 50 2007 341 346
150. C.S. Lieber Alcohol and hepatitis C Alcohol Res. Health 25 2001 245 254
151. G. Corrao, and S. Arico Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis Hepatology 27 1998 914 919 (Pubitemid 28160474)
152. G. Ostapowicz Role of alcohol in the progression of liver disease caused by hepatitis C virus infection Hepatology 27 1998 1730 1735 (Pubitemid 28264702)
153. A. Monto Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol Hepatology 36 2002 729 736 (Pubitemid 34977185)
154. S.H. Caldwell Hepatitis C infection by polymerase chain reaction in alcoholics: false-positive ELISA results and the influence of infection on a clinical prognostic score Am. J. Gastroenterol. 88 1993 1016 1021 (Pubitemid 23191088)
155. A. Pares Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury Hepatology 12 1990 1295 1299
156. M. Yamauchi Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C Am. J. Gastroenterol. 88 1993 39 43 (Pubitemid 23017940)
157. K. Moriya The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice Nat. Med. 4 1998 1065 1067 (Pubitemid 28417341)
158. T. Furutani Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein Gastroenterology 130 2006 2087 2098 (Pubitemid 43816966)
159. T.J. Liang, and T. Heller Pathogenesis of hepatitis C-associated hepatocellular carcinoma Gastroenterology 127 5 Suppl. 1 2004 S62 S71
160. G. Waris Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress J. Virol. 81 2007 8122 8130 (Pubitemid 47101498)
161. G.H. Syed, Y. Amako, and A. Siddiqui Hepatitis C virus hijacks host lipid metabolism Trends Endocrinol. Metab. 21 2010 33 40
162. M. Vidali Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C J. Hepatol. 48 2008 399 406
163. T. Kato Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice Cancer Sci. 94 2003 679 685 (Pubitemid 37160924)
164. K. Machida c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair Hepatology 52 2010 480 492
165. M. Valko Role of oxygen radicals in DNA damage and cancer incidence Mol. Cell. Biochem. 266 2004 37 56 (Pubitemid 39562306)
166. K.B. Schwarz Increased hepatic oxidative DNA damage in patients with hepatocellular carcinoma Dig. Dis. Sci. 46 2001 2173 2178 (Pubitemid 32955228)
167. S. Honda The semi-quantitative comparison of oxidative stress mediated DNA single and double strand breaks using terminal deoxynucleotidyl transferase mediated end labeling combined with a slot blot technique Free. Radic. Res. 38 2004 481 485 (Pubitemid 38618369)
168. B. Halliwell, and O.I. Aruoma DNA damage by oxygen-derived species: its mechanism and measurement in mammalian systems FEBS Lett. 281 1991 9 19
169. G. Vendemiale Oxidative stress in symptom-free HCV carriers: relation with ALT flare-up Eur. J. Clin. Invest. 31 2001 54 63 (Pubitemid 32151122)
170. S. Nishina Hepatitis C virus protein and iron overload induce hepatic steatosis through the unfolded protein response in mice Liver Int. 30 2010 683 692
171. H. Ming-Ju Hepatitis C virus E2 protein induces reactive oxygen species (ROS)-related fibrogenesis in the HSC-T6 hepatic stellate cell line J. Cell. Biochem. 112 2011 233 243
172. W. Lin HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFκB J. Biol. Chem. 286 2011 2665 2674
173. W.F. Reynolds A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection Genes Immun. 3 2002 345 349 (Pubitemid 38967562)
174. P. Nahon A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis J. Hepatol. 56 2012 426 432
175. R. Teixeira, L.A. Marcos, and S.L. Friedman Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: new insights into antifibrotic therapy in chronic hepatitis C Hepatol. Res. 37 2007 579 595 (Pubitemid 47009243)
176. R.M. Liu, and K.A. Gaston Pravia Oxidative stress and glutathione in TGF-β-mediated fibrogenesis Free Radic. Biol. Med. 48 2010 1 15
177. T. Kisseleva, and D.A. Brenner Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis J. Gastroenterol. Hepatol. 22 Suppl. 1 2007 S73 S78
178. A. Pereira Tde Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma Lab. Invest. 90 2010 1690 1703
179. S.S. Choi Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication Hepatology 54 2011 1580 1590
180. C. Mastruzzo, N. Crimi, and C. Vancheri Role of oxidative stress in pulmonary fibrosis Monaldi Arch. Chest Dis. 57 2002 173 176 (Pubitemid 36355994)
181. J.X. Jiang Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo Gastroenterology 139 2010 1375 1384
182. C. Loguercio, and A. Federico Oxidative stress in viral and alcoholic hepatitis Free Radic. Biol. Med. 34 2003 1 10 (Pubitemid 36043881)
183. M. Parola, and G. Robino Oxidative stress-related molecules and liver fibrosis J. Hepatol. 35 2001 297 306 (Pubitemid 32803489)
184. J.E. Klaunig The role of oxidative stress in chemical carcinogenesis Environ. Health Perspect. 106 Suppl. 1 1998 289 295 (Pubitemid 28196053)
185. B.R. Bacon, and R.S. Britton Hepatic injury in chronic iron overload: role of lipid peroxidation Chem. Biol. Interact. 70 1989 183 226 (Pubitemid 19164258)
186. T.E. Wiley Impact of alcohol on the histological and clinical progression of hepatitis C infection Hepatology 28 1998 805 809 (Pubitemid 28405433)
187. R. Bhattacharya, and M.C. Shuhart Hepatitis C and alcohol: interactions, outcomes, and implications J. Clin. Gastroenterol. 36 2003 242 252 (Pubitemid 36232637)
188. J. Westin Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection J. Viral Hepat. 9 2002 235 241 (Pubitemid 36005523)
189. S. Sachithanandan The effect of light drinking on HCV liver disease: the jury is still out Biomed. Pharmacother. 51 1997 295 297 (Pubitemid 27296842)
190. M. Vidali Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C Am. J. Gastroenterol. 103 2008 147 153
191. C.S. Lieber Relationships between nutrition, alcohol use, and liver disease Alcohol Res. Health 27 2003 220 231 (Pubitemid 40692072)
192. E. Gonzalez-Reimers Relative and combined effects of chronic alcohol consumption and HCV infection on serum zinc, copper, and selenium Biol. Trace Elem. Res. 132 2009 75 84
193. K. Machida Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog Proc. Natl. Acad. Sci. U. S. A. 106 2009 1548 1553
194. T.M. Donohue, N.A. Osna, and D.L. Clemens Recombinant Hep G2 cells that express alcohol dehydrogenase and cytochrome P450 2E1 as a model of ethanol-elicited cytotoxicity Int. J. Biochem. Cell Biol. 38 2006 92 101 (Pubitemid 41540720)
195. C.S. Lieber Biochemical mechanisms of alcohol-induced hepatic injury Alcohol Alcohol. Suppl. 1 1991 283 290
196. S. Mueller, G. Millonig, and H.K. Seitz Alcoholic liver disease and hepatitis C: a frequently underestimated combination World J. Gastroenterol. 15 2009 3462 3471
197. H. Hayashi Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron Am. J. Gastroenterol. 89 1994 986 988 (Pubitemid 24201831)
198. M. Yano Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C Am. J. Gastroenterol. 97 2002 133 137 (Pubitemid 34059776)
199. M. Yano A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan J. Gastroenterol. 39 2004 570 574 (Pubitemid 38996900)
200. E.J. Gane The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients Liver Int. 30 2010 1019 1026
201. T.L. Fong A pilot randomized, controlled trial of the effect of iron depletion on long-term response to α-interferon in patients with chronic hepatitis C J. Hepatol. 28 1998 369 374
202. R.J. Fontana Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial Hepatology 31 2000 730 736 (Pubitemid 30118643)
203. I. Gentile Iron depletion before HCV antiviral therapy: a pilot, randomized, controlled trial J. Clin. Apher. 24 2009 190 196
204. A. von Herbay Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study Free. Radic. Res. 27 1997 599 605 (Pubitemid 28051187)
205. S. Mahmood Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C Free. Radic. Res. 37 2003 781 785 (Pubitemid 36626438)
206. K. Falasca Treatment with silybin-vitamin E-phospholipid complex in patients with hepatitis C infection J. Med. Virol. 80 2008 1900 1906
207. A.K. Singal, S.C. Jampana, and S.A. Weinman Antioxidants as therapeutic agents for liver diseases Liver Int. 31 2011 1432 1448
208. J. Kato Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C J. Gastroenterol. 42 2007 830 836 (Pubitemid 47617461)
209. R. Kahl, S. Weinke, and H. Kappus Production of reactive oxygen species due to metabolic activation of butylated hydroxyanisole Toxicology 59 1989 179 194 (Pubitemid 19270046)
210. K. Houglum A pilot study of the effects of d-α-tocopherol on hepatic stellate cell activation in chronic hepatitis C Gastroenterology 113 1997 1069 1073 (Pubitemid 27418958)
211. A. Melhem Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial J. Clin. Gastroenterol. 39 2005 737 742 (Pubitemid 41177097)
212. E. Gabbay Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial World J. Gastroenterol. 13 2007 5317 5323 (Pubitemid 47559461)
213. M.P. Look Interferon/antioxidant combination therapy for chronic hepatitis C-a controlled pilot trial Antiviral Res. 43 1999 113 122 (Pubitemid 29415658)
214. J.R. Lancaster Nitric Oxide: Principles and Actions 1996 Academic Press San Diego
215. J.S. Beckman, and W.H. Koppenol Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly Am. J. Physiol. 271 5 Pt 1 1996 C1424 C1437
216. P.A. Loughran Monomeric inducible nitric oxide synthase localizes to peroxisomes in hepatocytes Proc. Natl. Acad. Sci. U. S. A. 102 2005 13837 13842 (Pubitemid 41377665)
217. D.B. Stolz Peroxisomal localization of inducible nitric oxide synthase in hepatocytes Hepatology 36 2002 81 93 (Pubitemid 34700765)
218. R.A. Egler Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1 Oncogene 24 2005 8038 8050 (Pubitemid 41746747)
219. J.D. Lambeth, T. Kawahara, and B. Diebold Regulation of Nox and Duox enzymatic activity and expression Free Radic. Biol. Med. 43 2007 319 331 (Pubitemid 46978416)
220. N.Y. Spencer Control of hepatic nuclear superoxide production by glucose 6-phosphate dehydrogenase and NADPH oxidase-4 J. Biol. Chem. 286 2011 8977 8987
221. C. Isaac, J.W. Pollard, and U.T. Meier Intranuclear endoplasmic reticulum induced by Nopp 140 mimics the nucleolar channel system of human endometrium J. Cell Sci. 114 Pt 23 2001 4253 4264 (Pubitemid 33138662)
222. J. Kuroda The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells Genes Cells 10 2005 1139 1151 (Pubitemid 41830073)
223. C.F. Lee Nox4 is a novel inducible source of reactive oxygen species in monocytes and macrophages and mediates oxidized low density lipoprotein-induced macrophage death Circ. Res. 106 2010 1489 1497
224. 2 drives DNA oxidation resulting in 8-OHdG as urinary biomarker and hemangioendothelioma formation Antioxid. Redox Signal. 12 2010 933 943
225. K.D. Pendergrass The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus Biochem. Biophys. Res. Commun. 384 2009 149 154
226. L. Zhang New insight into the Nox4 subcellular localization in HEK293 cells: first monoclonal antibodies against Nox4 Biochimie 93 2011 457 468
227. I. Takac The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4 J. Biol. Chem. 286 2011 13304 13313
228. M. Mofarrahi Regulation of proliferation of skeletal muscle precursor cells by NADPH oxidase Antioxid. Redox Signal. 10 2008 559 574
229. S.I. Dikalov Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production Free Radic. Biol. Med. 45 2008 1340 1351
230. I. Helmcke Identification of structural elements in Nox1 and Nox4 controlling localization and activity Antioxid. Redox Signal. 11 2009 1279 1287
231. K.D. Martyn Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases Cell. Signal. 18 2006 69 82 (Pubitemid 41415716)
232. L. Serrander NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation Biochem. J. 406 2007 105 114 (Pubitemid 47264740)
233. K. Block, Y. Gorin, and H.E. Abboud Subcellular localization of Nox4 and regulation in diabetes Proc. Natl. Acad. Sci. U. S. A. 106 2009 14385 14390
234. L.L. Hilenski Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 24 2004 677 683 (Pubitemid 38451603)
235. O. Teufelhofer Superoxide generation from Kupffer cells contributes to hepatocarcinogenesis: studies on NADPH oxidase knockout mice Carcinogenesis 26 2005 319 329 (Pubitemid 40246553)
236. H. Ohshima, M. Tatemichi, and T. Sawa Chemical basis of inflammation-induced carcinogenesis Arch. Biochem. Biophys. 417 2003 3 11 (Pubitemid 36960042)
237. J. Mitsushita, J.D. Lambeth, and T. Kamata The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation Cancer Res. 64 2004 3580 3585 (Pubitemid 38657935)
238. K. Irani, and P.J. Goldschmidt-Clermont Ras, superoxide and signal transduction Biochem. Pharmacol. 55 1998 1339 1346 (Pubitemid 28298512)
239. R.B. Ray Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype J. Virol. 70 1996 4438 4443 (Pubitemid 26187445)
240. K. Rokutan NADPH oxidases in the gastrointestinal tract: a potential role of Nox1 in innate immune response and carcinogenesis Antioxid. Redox Signal. 8 2006 1573 1582 (Pubitemid 44726332)
241. K. Machida Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway J. Virol. 83 2009 12590 12600
242. M. Hassan Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways Hepatology 49 2009 1469 1482
243. E.C. Vaquero Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells J. Biol. Chem. 279 2004 34643 34654 (Pubitemid 39318094)
244. T. Mochizuki Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells Oncogene 25 2006 3699 3707 (Pubitemid 43980491)
245. H. Cai NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease Circ. Res. 96 2005 818 822 (Pubitemid 40604964)
246. M. Zhang NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis Proc. Natl. Acad. Sci. USA 107 2010 18121 18126
247. D.J. McCrann Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidy Blood 114 2009 1243 1249
248. J.J. Haddad, and S.C. Land A non-hypoxic, ROS-sensitive pathway mediates TNF-α-dependent regulation of HIF-1α FEBS Lett. 505 2001 269 274 (Pubitemid 32896679)
249. X. Lin A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation Proc. Natl. Acad. Sci. U. S. A. 105 2008 174 179
250. 2 sensing J. Biol. Chem. 275 2000 25130 25138
251. C.L. Lu NADPH oxidase DUOX1 and DUOX2 but not NOX4 are independent predictors in hepatocellular carcinoma after hepatectomy Tumour Biol. 32 2011 1173 1182
252. Vespasiani-Gentilucci, U., et al. Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease. Mod. Pathol; 2011 [Electronic publication].
253. M.Y. Sheikh Hepatitis C virus infection: molecular pathways to metabolic syndrome Hepatology 47 2008 2127 2133 (Pubitemid 351945577)
254. H. Knobler, and A. Schattner TNF-α, chronic hepatitis C and diabetes: a novel triad QJM 98 2005 1 6
255. Y. Ishizaka Association between hepatitis C virus core protein and carotid atherosclerosis Circ. J. 67 2003 26 30 (Pubitemid 36119617)
256. G. Targher Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C J. Hepatol. 46 2007 1126 1132 (Pubitemid 46669732)
257. K. Koike, K. Moriya, and Y. Matsuura Animal models for hepatitis C and related liver disease Hepatol. Res. 40 2010 69 82
258. P.C. Schulze, and R.T. Lee Oxidative stress and atherosclerosis Curr. Atheroscler. Rep. 7 2005 242 248 (Pubitemid 40796758)
259. A. Ramachandran Mitochondria, nitric oxide, and cardiovascular dysfunction Free Radic. Biol. Med. 33 2002 1465 1474 (Pubitemid 35351589)
260. J.L. Evans, B.A. Maddux, and I.D. Goldfine The molecular basis for oxidative stress-induced insulin resistance Antioxid. Redox Signal. 7 2005 1040 1052 (Pubitemid 40967154)
261. H. Mitsuyoshi Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C Hepatol. Res. 38 2008 348 353 (Pubitemid 351321177)
262. A.C. Oliveira Insulin resistance and not steatosis is associated with modifications in oxidative stress markers in chronic hepatitis C, non-3 genotype Free. Radic. Res. 43 2009 1187 1194
263. H. Aizaki Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts Virology 324 2004 450 461 (Pubitemid 38797861)
264. B.D. Lindenbach, and C.M. Rice Unravelling hepatitis C virus replication from genome to function Nature 436 2005 933 938 (Pubitemid 41191668)
265. J. Ye Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation Proc. Natl. Acad. Sci. U. S. A. 100 2003 15865 15870 (Pubitemid 38021081)
266. C. Wang Identification of FBL2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA replication Mol. Cell 18 2005 425 434 (Pubitemid 40704757)
267. H. Yao, and J. Ye Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells J. Biol. Chem. 283 2008 849 854
268. S.B. Kapadia Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I J. Virol. 81 2007 374 383 (Pubitemid 44975176)
269. F. Amemiya Targeting lipid metabolism in the treatment of hepatitis C virus infection J. Infect. Dis. 197 2008 361 370 (Pubitemid 351263417)
270. T. Bader Fluvastatin inhibits hepatitis C replication in humans Am. J. Gastroenterol. 103 2008 1383 1389 (Pubitemid 351813920)
271. M. Sata Hepatitis C virus infection in patients with clinically diagnosed alcoholic liver diseases J. Viral Hepat. 3 1996 143 148 (Pubitemid 126734181)
272. M. Oshita Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C Hepatology 20 1994 1115 1120 (Pubitemid 24323554)
273. F. Pessione Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C Hepatology 27 1998 1717 1722 (Pubitemid 28264700)
274. M. Romero-Gomez Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption Dig. Liver Dis. 33 2001 698 702 (Pubitemid 33107671)
275. M. Sawada Effects of alcohol on the replication of hepatitis C virus Alcohol Alcohol. Suppl. 1B 1993 85 90 (Pubitemid 24082971)
276. M. Carriere Low density lipoprotein receptor transcripts correlates with liver hepatitis C virus RNA in patients with alcohol consumption J. Viral Hepat. 13 2006 633 642 (Pubitemid 44232548)
277. S.L. Cromie Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre J. Hepatol. 25 1996 821 826 (Pubitemid 27008112)
278. T. Zhang Alcohol potentiates hepatitis C virus replicon expression Hepatology 38 2003 57 65 (Pubitemid 36775796)
279. K. Trujillo-Murillo Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity J. Viral Hepat. 14 2007 608 617 (Pubitemid 47258261)
280. E.M. McCartney Alcohol metabolism increases the replication of hepatitis C virus and attenuates the antiviral action of interferon J. Infect. Dis. 198 2008 1766 1775
281. G. Barba Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets Proc. Natl. Acad. Sci. U. S. A. 94 1997 1200 1205 (Pubitemid 27087828)
282. A. Lonardo Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease Gastroenterology 126 2004 586 597 (Pubitemid 38182315)
283. N. Appel Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly PLoS Pathog. 4 2008 e1000035
284. A.I. Cederbaum Microsomal generation of reactive oxygen species and their possible role in alcohol hepatotoxicity Alcohol Alcohol. 1 1991 291 296 Suppl
285. C.S. Lieber Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis Alcohol 34 2004 9 19 (Pubitemid 40163989)
286. D.W. Crabb, and S. Liangpunsakul Alcohol and lipid metabolism J. Gastroenterol. Hepatol. 21 Suppl. 3 2006 S56 S60
287. N. Kaplowitz, and C. Ji Unfolding new mechanisms of alcoholic liver disease in the endoplasmic reticulum J. Gastroenterol. Hepatol. 21 Suppl. 3 2006 S7 S9
288. J. Choi Redox modulation of the hepatitis C virus replication complex is calcium dependent Free Radic. Biol. Med. 41 2006 1488 1498 (Pubitemid 44466731)
289. H. Huang, Y. Chen, and J. Ye Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E Proc. Natl. Acad. Sci. U. S. A. 104 2007 18666 18670 (Pubitemid 350210754)
290. M. Kuroki Arsenic trioxide inhibits hepatitis C virus RNA replication through modulation of the glutathione redox system and oxidative stress J. Virol. 83 2008 2338 2348
291. S.B. Kapadia, and F.V. Chisari Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids Proc. Natl. Acad. Sci. U. S. A. 102 2005 2561 2566 (Pubitemid 40279416)
292. T. von Hahn Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells Hepatology 43 2006 932 942 (Pubitemid 43724618)
293. M. Yano Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase Hepatology 50 2009 678 688
294. C. Fillebeen Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C virus J. Biol. Chem. 280 2005 9049 9057 (Pubitemid 40409598)
295. T.L. Leto, and M. Geiszt Role of Nox family NADPH oxidases in host defense Antioxid. Redox Signal. 8 2006 1549 1561 (Pubitemid 44726330)
296. G. Waris Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication J. Virol. 79 2005 1569 1580 (Pubitemid 40459104)
297. Z. Zhu Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase? Hepatology 52 2010 1897 1905
298. Z. Zhu Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury Hepatology 48 2008 1430 1439
299. E. Ferrari Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli J. Virol. 73 1999 1649 1654 (Pubitemid 29036824)
300. V. Lohmann, J.O. Koch, and R. Bartenschlager Processing pathways of the hepatitis C virus proteins J. Hepatol. 24 1996 11 19 (Pubitemid 26267058)
301. J. Marcotrigiano, and T. Tellinghuisen Purification and crystallization of NS5A domain I of hepatitis C virus Methods Mol. Biol. 510 2009 85 94
302. T.L. Tellinghuisen The NS5A protein of hepatitis C virus is a zinc metalloprotein J. Biol. Chem. 279 2004 48576 48587 (Pubitemid 39625732)
303. K. Hemminki Urinary sulfur containing metabolites after administration of ethanol, acetaldehyde and formaldehyde to rats Toxicol. Lett. 11 1982 1 6 (Pubitemid 12113937)
304. J. Zheng N-Acetylcysteine interacts with copper to generate hydrogen peroxide and selectively induce cell death Cancer Lett. 298 2010 186 194
305. A.L. Wang A dual effect of N-acetylcysteine on acute ethanol-induced liver damage in mice Hepatol. Res. 34 2006 199 206
306. Y.R. Chen, A. Shrivastava, and T.H. Tan Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate Oncogene 20 2001 367 374 (Pubitemid 32142326)
307. K. Groenbaek The effect of antioxidant supplementation on hepatitis C viral load, transaminases and oxidative status: a randomized trial among chronic hepatitis C virus-infected patients Eur. J. Gastroenterol. Hepatol. 18 2006 985 989 (Pubitemid 44213042)
308. K. Kuwana Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: a multivariate analysis in 343 patients J. Gastroenterol. Hepatol. 12 1997 149 155 (Pubitemid 27096387)
309. G. Szabo Pathogenic interactions between alcohol and hepatitis C Curr. Gastroenterol. Rep. 5 2003 86 92 (Pubitemid 38899276)
310. S. Mochida Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis Alcohol. Clin. Exp. Res. 20 9 Suppl. 1996 371A 377A (Pubitemid 27009770)
311. N.A. Osna Hepatitis C virus and ethanol alter antigen presentation in liver cells World J. Gastroenterol. 15 2009 1201 1208
312. C.R. Plumlee Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells Virol. J. 2 2005 89
313. O. Norkina Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes Alcohol. Clin. Exp. Res. 32 2008 1565 1573
314. D. Di Bona Oxidative stress inhibits IFN-α-induced antiviral gene expression by blocking the JAK-STAT pathway J. Hepatol. 45 2006 271 279
315. R.C. Cheung Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes Am. J. Gastroenterol. 100 2005 2186 2193
316. K. Chayama Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection Hepatology 25 1997 745 749 (Pubitemid 27106464)
317. E. Mita Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer Dig. Dis. Sci. 39 1994 977 982 (Pubitemid 24188839)
318. P. Halfon, and S. Locarnini Hepatitis C virus resistance to protease inhibitors J. Hepatol. 55 2011 192 206
319. K.E. Sherman Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease Hepatology 30 1999 265 270 (Pubitemid 29300595)
320. K. Takahashi Difference in quasispecies of the hypervariable region 1 of hepatitis C virus between alcoholic and non-alcoholic patients J. Gastroenterol. Hepatol. 16 2001 416 423 (Pubitemid 32397654)
321. J. Moreno Garcia Analysis of hepatitis C viral quasispecies in liver transplantation Transplant. Proc. 35 2003 1838 1840 (Pubitemid 37093732)
322. S. Seronello Ethanol and reactive species increase basal sequence heterogeneity of hepatitis C virus and produce variants with reduced susceptibility to antivirals PLoS One 6 2011 e27436
323. J. Adachi Comparative study on ethanol elimination and blood acetaldehyde between alcoholics and control subjects Alcohol. Clin. Exp. Res. 13 1989 601 604 (Pubitemid 19270865)
324. N.C. Tsai Effect of iron depletion on long-term response to interferon-α in patients with chronic hepatitis C who previously did not respond to interferon therapy Am. J. Gastroenterol. 92 1997 1831 1834 (Pubitemid 27440900)
325. S. Fargion Iron reduction and sustained response to interferon-α therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study Am. J. Gastroenterol. 97 2002 1204 1210 (Pubitemid 34478123)
326. S. Fargion Liver iron influences the response to interferon α therapy in chronic hepatitis C Eur. J. Gastroenterol. Hepatol. 9 1997 497 503 (Pubitemid 27214456)
327. G.R. Buettner, and B.A. Jurkiewicz Catalytic metals, ascorbate and free radicals: combinations to avoid Radiat. Res. 145 1996 532 541 (Pubitemid 26127160)
328. P.R. Grant Combination therapy with interferon-α plus N-acetyl cysteine for chronic hepatitis C: a placebo controlled double-blind multicentre study J. Med. Virol. 61 2000 439 442 (Pubitemid 30450684)
329. I.H. McKillop, and L.W. Schrum Alcohol and liver cancer Alcohol 35 2005 195 203 (Pubitemid 41079923)
330. Q. Kong, and C.L. Lin Oxidative damage to RNA: mechanisms, consequences, and diseases Cell. Mol. Life Sci. 67 2010 1817 1829
331. H. Kamiya Incorporation of 8-hydroxyguanosine (8-oxo-7,8- dihydroguanosine) 5′-triphosphate by bacterial and human RNA polymerases Free Radic. Biol. Med. 46 2009 1703 1707
332. A.R. Simon Activation of the JAK-STAT pathway by reactive oxygen species Am. J. Physiol. 275 6 Pt 1 1998 C1640 C1652
333. B. Burlando Ligand-independent tyrosine kinase signalling in RTH 149 trout hepatoma cells: comparison among heavy metals and pro-oxidants Cell. Physiol. Biochem. 13 2003 147 154 (Pubitemid 36928653)
334. O. Norkina Acute alcohol activates STAT3, AP-1, and Sp-1 transcription factors via the family of Src kinases to promote IL-10 production in human monocytes J. Leukoc. Biol. 82 2007 752 762 (Pubitemid 47367167)
335. S.R. Lee Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor J. Biol. Chem. 273 1998 15366 15372
336. D.A. Dickinson, and H.J. Forman Glutathione in defense and signaling: lessons from a small thiol Ann. N. Y. Acad. Sci. 973 2002 488 504 (Pubitemid 36131049)
337. S. Osada Vascular endothelial growth factor protects hepatoma cells against oxidative stress-induced cell death J. Gastroenterol. Hepatol. 21 2006 988 993 (Pubitemid 43823283)
338. H.J. Forman, and E. Cadenas Oxidative Stress and Signal Transduction 1997 Chapman & Hall New York
339. T. Tsutsumi Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice Hepatology 38 2003 820 828 (Pubitemid 37221665)
340. G. Svegliati-Baroni Intracellular signaling pathways involved in acetaldehyde-induced collagen and fibronectin gene expression in human hepatic stellate cells Hepatology 33 2001 1130 1140 (Pubitemid 32378212)
341. J.B. Hoek, and J.G. Pastorino Cellular signaling mechanisms in alcohol-induced liver damage Semin. Liver Dis. 24 2004 257 272 (Pubitemid 39167684)
342. E. Thomas Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models Hepatology 53 2010 32 41
343. K. Mori Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system Virus Res. 157 2011 61 70
344. J.J. Feld, and J.H. Hoofnagle Mechanism of action of interferon and ribavirin in treatment of hepatitis C Nature 436 2005 967 972 (Pubitemid 41191673)
345. L. De Franceschi Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage Hepatology 31 2000 997 1004 (Pubitemid 30169949)
346. I. Grattagliano Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia Clin. Pharmacol. Ther. 78 2005 422 432 (Pubitemid 41393677)
347. Y. Huang Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication? Virology 364 2007 1 9 (Pubitemid 46829271)
348. N. El-Hage HIV-1 coinfection and morphine coexposure severely dysregulate hepatitis C virus-induced hepatic proinflammatory cytokine release and free radical production: increased pathogenesis coincides with uncoordinated host defenses J. Virol. 85 2011 11601 11614
349. T. Akaike Viral mutation accelerated by nitric oxide production during infection in vivo FASEB J. 14 2000 1447 1454 (Pubitemid 30439754)
350. M. Dorner A genetically humanized mouse model for hepatitis C virus infection Nature 474 2011 208 211
351. G. Ideo Antioxidant drugs combined with α-interferon in chronic hepatitis C not responsive to α-interferon alone: a randomized, multicentre study Eur. J. Gastroenterol. Hepatol. 11 1999 1203 1207 (Pubitemid 29531338)
352. F. Morisco Tomato-based functional food as interferon adjuvant in HCV eradication therapy J. Clin. Gastroenterol. 38 6 Suppl. 2004 S118 S120
353. K. Saeian High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard α-interferon and ribavirin Aliment. Pharmacol. Ther. 20 2004 1189 1193 (Pubitemid 39657953)
354. K. Hino α-Tocopherol [corrected] and ascorbic acid attenuates the ribavirin [corrected] induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients J. Gastroenterol. Hepatol. 21 2006 1269 1275 (Pubitemid 44034339)
355. J.J. Feld S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders Gastroenterology 140 2011 830 839
356. M. Filipowicz S-adenosyl-methionine and betaine improve early virological response in chronic hepatitis C patients with previous nonresponse PLoS One 5 2011 e15492